Skip to content

support@abbonews.com

Menu

US Markets
Business
Technology
News
Featured
Press Release

US Markets
Business
Technology
News
Featured
Press Release

US Markets
Business
Technology
News
Featured
Press Release

NASDAQ: RXRX

Recursion (NASDAQ: RXRX) to Acquire Smaller Peer Exscientia in $688 Million Deal

Jennifer Tacker / 8 August 2024

NEW YORK – Recursion Pharmaceuticals (NASDAQ: RXRX), a biotech firm that uses artificial intelligence to discover new drug candidates, has […]

Recursion (NASDAQ: RXRX) to Acquire Smaller Peer Exscientia in $688 Million Deal Read More »

RXRX stock

RXRX stock

Business, News, US Markets

Recursion Pharmaceuticals (NASDAQ: RXRX) Shares Rose Post Launch of LOWE Drug Discovery Software

Zabih Ullah / 10 January 2024

Recursion Pharmaceuticals (NASDAQ: RXRX) shares rose by over 3% in the extended trading Tuesday after the TechBio company revealed its

Recursion Pharmaceuticals (NASDAQ: RXRX) Shares Rose Post Launch of LOWE Drug Discovery Software Read More »

Recursion Pharmaceuticals

Recursion Pharmaceuticals

Business, News, Technology, US Markets

Recursion Pharmaceuticals (NASDAQ: RXRX) Shares Skyrocket on NVIDIA’s $50 Million Investment

Kevin Putnam / 13 July 2023

Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) skyrocketed 78.2% on Wednesday after the company received a significant investment of $50 million

Recursion Pharmaceuticals (NASDAQ: RXRX) Shares Skyrocket on NVIDIA’s $50 Million Investment Read More »

Company

About Us

Team

Contact Us

Categories

US Market

Business

Technology

News

Featured

Press Release

Legal

Privacy Policy

Disclaimer

Copyright © 2024 abbonews.com.